Diabetes Mellitus Casos clínicos en atención primaria
4. ¿Cuál es la mejor estrategia en un paciente diabético que recibe altas dosis de estatinas y presenta valores de 142 mg/dl? 5. Un paciente diabético obeso le comenta su preocupación de consumir sibutramina por el riesgo de desarrollar enfermedad valvular. ¿Cuál es su opinión al respecto?
Lecturas recomendadas 1. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-572. 2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakslo M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229-234. 3.Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet 2003; 361:2005-016. 4.The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Lancet. 2000;355:253-259. 5. Lindholm LH, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:1004-1010 6. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999; 354:617-21. 7. Riddle MC, Rosenstock J, Gerich J. The Treat-to-Target Trial. Diabetes Care 2003;26:3080-3086 8. Wartofsky L. Update in Endocrinology. Annals of Internal Medicine. 2005; 143(9):673-682 9. Comi R. Treatment of Type 2 Diabetes Mellitus: A Weighty Enigma. Annals of Internal Medicine. 2005; 143(8): 609-610 10. Bloomgarden Z. Developments in Diabetes and Insulin Resistance Diabetes Care. 2006; 29: 161-167 11. Kahn R, Buse J, Ferrannini E, Stern M. The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2005; 28: 22892304
149